Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1142 of 1,261
  1. US 6827946

    Compositions containing both sedative and non-sedative antihistamines

    Collegium Pharmaceutical, Inc. Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  2. US 6828416

    Recombinant multivalent malarial vaccine against Plasmodium falciparum

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  3. US 6828471

    Mice models of human prostate cancer

    The Regents of the University of California Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  4. US 6828351

    Methods and compositions for regulating memory consolidation

    Sention, Inc. Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  5. US 6828299

    Polyhydroxy glycopeptide derivatives

    Theravance, Inc. Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  6. US 6827935

    Method of and compositions for immunization with the pseudomonas V antigen

    The Regents of the University of California Β· Granted Dec 7, 2004 Β· Expires Dec 2, 2024

    expired
  7. US 6825224

    Prodrugs of carbamate inhibitors of IMPDH

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  8. US 6825259

    Resin-coated scale-like inorganic particles and cosmetics with the same blended therein

    CATALYSTS & CHEMICALS INDUSTRIES CO., LTD. Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  9. US 6825323

    Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same

    The United States of America as represented by the Secretary of the Army Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  10. US 6825222

    Modulators of peroxisome proliferator activated receptors

    Ligand Pharmaceuticals Incorporated Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  11. US 6825213

    &bgr;3-adrenoreceptor agonists, agonist compositions and methods of using

    Molecular Design International, Inc. Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  12. US 6825186

    Method and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  13. US 6825165

    Betacellulin modification

    Takeda Chemical Industries Ltd. Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  14. US 6825031

    Storage of materials

    Nektar Therapeutics Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  15. US 6825008

    Expressed ligand—vascular intercellular signalling molecule

    REGENERON PHARMACEUTICALS, INC. Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  16. US 6824978

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  17. US 6824976

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  18. US 6824769

    Optimal compositions and methods thereof for treating HCV infections

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  19. US 6825326

    PSCA: prostate stem cell antigen and uses thereof

    The Regents of the University of California Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  20. US 6825167

    Genetic modification of endostatin

    Regents of the University of Minnesota Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  21. US 6825190

    Protein kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 30, 2004 Β· Expires Nov 25, 2024

    expired
  22. US 6822071

    Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease

    The Regents of the University of California Β· Granted Nov 23, 2004 Β· Expires Nov 18, 2024

    expired
  23. US 6821750

    ABCG8 vectors, host cells, and method of making

    The Board of Regents of the University of Texas System Β· Granted Nov 23, 2004 Β· Expires Nov 18, 2024

    expired
  24. US 6821742

    Conformational and topological protein regulation

    The Regents of the University of California Β· Granted Nov 23, 2004 Β· Expires Nov 18, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.